January 3, 2008 - Medical Simulation Corp. and Edwards Lifesciences Corp. will launch the Edwards SAPIEN Transcatheter Heart Valve (THV) Training Program in Europe to provide commercial product training for surgeons and cardiologists.

The Edwards SAPIEN transcatheter aortic heart valve with the RetroFlex transfemoral delivery system received CE Mark approval in September 2007, and the Edwards SAPIEN valve with the Ascendra transapical delivery system was CE approved in December 2007.

January 3, 2008 - A patient’s physical activity status is a significant and robust predictor of all-cause mortality in patients with varying levels of ambulatory function, according to a new study that compares death rates between active and sedentary patients who have peripheral artery disease (PAD) with intermittent claudication published in the January 2008 issue of the Journal for Vascular Surgery.

January 3, 2008 – Abiomed Inc. selected Tufts-New England Medical Center (Tufts-NEMC) as a “Center of Excellence” for its cardiac program, having achieved outstanding clinical outcomes with the recovery of the native heart.

As a Center of Excellence, Tufts-NEMC will share best practices related to VAD implantation and patient care with other hospitals and medical centers. This award is granted to top institutions in the country for achieving significant clinical outcomes and their focus on recovery of the native heart. Tufts-NEMC’s outcomes are among the best in the country.

January 3, 2008 - A modular stent graft that inserts multiple, caudally-directed branches to the visceral arteries to repair a thoracoabdominal aortic aneurysm (TAAA) can offer a safer surgical method for patients in need of this surgery, according to a recent study in the January 2008 issue of the Journal of Vascular Surgery.

January 2, 2008 – Allergic-like reactions to gadolinium-containing contrast injections in adults and pediatric patients, under the age of 19, are rare, according to a study conducted by researchers at the University of Michigan Health Systems in Ann Arbor, MI,.
Studying 78,353 gadolinium-containing contrast injections over five years, acute allergic-like reactions occurred after 54 injections, 48 reactions involved adults and six occurred in pediatric patients. Seventy-four percent of these reactions were mild, 19 percent were moderate and seven percent were marked as severe.

December 29, 2007 - Boston Scientific Corp. received CE Mark approval for its LIVIAN cardiac resynchronization therapy defibrillator (CRT-D), which treats heart failure and is designed to help protect patients at risk of sudden cardiac death by monitoring heartbeats in heart failure patients and delivering small electrical impulses that may improve the heart’s pumping ability.

December 28, 2007 - The data converter and amplifiers market for portable imaging systems will reach $582.7 million in 2011 up from $316 million in 2006, according to research from Frost & Sullivan.

December 28, 2007 – State-of-the-art digital Picture Archiving and Communications Systems (PACS) technology is changing the way Britain’s National Health Service captures, records and uses patient X-rays and scans in every hospital trust, the Department of Health said Thursday.

December 27, 2007 - After a longer-than-expected maintenance shutdown, production of radioisotopes for molecular imaging and targeted therapy is back online at the National Research Universal (NRU) reactor in Chalk River, Ontario. The reactor was returned to service following direct intervention by the Canadian government, which in effect over-ruled the safety concerns of the Canadian Nuclear Safety Commission (CNSC).

December 27, 2007 - Several new studies on genetics and stem cell research, along with studies that continue to debate the use of stents to clear coronary artery blockages are among the top research advances in heart disease and stroke for 2007, said Daniel W. Jones, M.D., president of the American Heart Association.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now